Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) shares saw an uptick in trading volume on Wednesday . 636,787 shares were traded during mid-day trading, an increase of 289% from the previous session's volume of 163,727 shares.The stock last traded at $17.38 and had previously closed at $15.97.
Terumo Stock Down 0.7%
The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $25.82 billion, a price-to-earnings ratio of 33.54 and a beta of 0.79. The stock has a fifty day moving average of $17.78 and a 200-day moving average of $18.37.
Terumo (OTCMKTS:TRUMY - Get Free Report) last issued its quarterly earnings results on Wednesday, May 14th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.15 by ($0.07). Terumo had a net margin of 11.28% and a return on equity of 8.48%. The business had revenue of $1.79 billion for the quarter, compared to analysts' expectations of $1.79 billion.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
